MPO and chronic kidney disease: The lack of association between C-Alb levels and smoking status in the present study and MPO concentration in other studies may indicate that smoking is a minor source of cyanate, whereas uraemia is the more dominant source of carbamylation in CKD patients [16–18, 21].